City
Epaper

Quantum computing, AI to revolutionise drug discovery in India: Ex-ICMR chief

By IANS | Updated: February 20, 2025 16:35 IST

New Delhi, Feb 20 Quantum computing and Artificial Intelligence (AI) to revolutionise drug discovery in India, and enable ...

Open in App

New Delhi, Feb 20 Quantum computing and Artificial Intelligence (AI) to revolutionise drug discovery in India, and enable the country to become a global hub for pharmaceutical advancements, said Dr. Balram Bhargava, Former Director General, ICMR.

He was speaking at the 9th "International Symposium on Current Trends in Drug Discovery Research” at CSIR-Central Drug Research Institute, Lucknow.

“India's strength in drug discovery stems from its rich heritage in chemistry, making it a global hub for pharmaceutical advancements,” said Bhargava, Dean and Senior Consultant, Holy Family Hospital, New Delhi.

“The integration of Quantum Computing and Artificial Intelligence (AI) is set to revolutionise drug discovery, accelerating research and reducing costs,” he added.

The expert noted that India has consistently demonstrated its ability to produce high-quality, affordable medicines, ensuring healthcare accessibility worldwide. However, challenges such as the availability of Active Pharmaceutical Ingredients (APIs) and the need for new drug discoveries remain key areas of focus.

Further, Bhargava called for collaborations to boost India's pharmaceutical success, as seen in the development of vaccines.

“Market shaping is equally important, ensuring that innovations reach the masses while maintaining India's leadership in cost-effective healthcare solutions,” he said.

The event, aimed to discuss new strategies in synthetic and medicinal chemistry in the country, also witnessed the presence of global experts from the universities of Florida and Minnesota in the US. They spoke on breakthroughs in pain management strategies as well as the need to develop new antimicrobial agents with novel mechanisms.

Meanwhile, Dr. Arindam Talukdar from CSIR-Indian Institute of Chemical Biology (IICB), Kolkata, shared his research findings on the stimulation of agonism-antagonism in TLR7 modulators via complex interactions between chemical subunits.

The TLR7 is an endosomal TLR protein that helps the body to recognise and respond to viruses and bacteria.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentRaza Murad remembers 'the one man acting institution' Dilip Kumar

InternationalTrump considering "joint venture" with Iran to secure Strait of Hormuz after ceasefire deal; Report

NationalSupreme Court flags continued discrimination faced by people from North East region

International13,000 strikes, 13 US troops killed in war with Iran​

International'India-EU partnership to play key role in New World Order'

Health Realted Stories

HealthJharkhand HC seeks detailed probe report on HIV-infected blood transfusion in Chaibasa

HealthTejashwi Yadav targets Health Minister Mangal Pandey over viral Gaya hospital video

Health‘Poshan Pakhwada 2026’ to focus on maximising brain development in 1st 6 years of life

HealthTurmeric Milk Benefits: Know When to Drink It for Best Results

HealthWhat Is Second-Hand Stress? How Others’ Anxiety Can Affect Your Mental Health